Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional

Background: The use of systemic chemotherapy has survival and palliation benefits in oncological patients. Mortality at 30 days after the administration of systemic chemotherapy is considered as a quality and safety indicator of oncological patient care. The international mortality threshold is 5%,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pulgar B.,Dahiana, Yáñez B.,Nicolás, Ortega G.,Francisco
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2019
Materias:	Antineoplastic Agents Benchmarking Mortality
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000700887
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872019000700887
record_format	dspace
spelling	oai:scielo:S0034-988720190007008872019-11-04Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regionalPulgar B.,DahianaYáñez B.,NicolásOrtega G.,Francisco Antineoplastic Agents Benchmarking Mortality Background: The use of systemic chemotherapy has survival and palliation benefits in oncological patients. Mortality at 30 days after the administration of systemic chemotherapy is considered as a quality and safety indicator of oncological patient care. The international mortality threshold is 5%, which is the figure used to compare institutions. Aim: To assess mortality at 30 days after the administration of ambulatory systemic chemotherapy in a regional referral center in adult cancer patients. Material and Methods: Retrospective observational study of patients receiving ambulatory systemic chemotherapy in the oncology service of a regional public hospital during 2018. The 30-day mortality rate was calculated. Demographic characteristics, baseline disease and the treatment received were recorded. Results: During the study period, 690 patients received ambulatory systemic chemotherapy. Chemotherapy was palliative in 76% of patients and 53% received a first line treatment. Seventeen (2.5%) died within 30 days of treatment administration. Nine deaths (52.9%) were definitely related to treatment and sepsis was the most frequent cause. Conclusions: Our mortality rates are similar to international data. This type of audit reviews local outcomes and identifies factors contributing to mortality aiming to improve standards of care.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.147 n.7 20192019-07-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000700887es10.4067/S0034-98872019000700887
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Antineoplastic Agents Benchmarking Mortality
spellingShingle	Antineoplastic Agents Benchmarking Mortality Pulgar B.,Dahiana Yáñez B.,Nicolás Ortega G.,Francisco Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional
description	Background: The use of systemic chemotherapy has survival and palliation benefits in oncological patients. Mortality at 30 days after the administration of systemic chemotherapy is considered as a quality and safety indicator of oncological patient care. The international mortality threshold is 5%, which is the figure used to compare institutions. Aim: To assess mortality at 30 days after the administration of ambulatory systemic chemotherapy in a regional referral center in adult cancer patients. Material and Methods: Retrospective observational study of patients receiving ambulatory systemic chemotherapy in the oncology service of a regional public hospital during 2018. The 30-day mortality rate was calculated. Demographic characteristics, baseline disease and the treatment received were recorded. Results: During the study period, 690 patients received ambulatory systemic chemotherapy. Chemotherapy was palliative in 76% of patients and 53% received a first line treatment. Seventeen (2.5%) died within 30 days of treatment administration. Nine deaths (52.9%) were definitely related to treatment and sepsis was the most frequent cause. Conclusions: Our mortality rates are similar to international data. This type of audit reviews local outcomes and identifies factors contributing to mortality aiming to improve standards of care.
author	Pulgar B.,Dahiana Yáñez B.,Nicolás Ortega G.,Francisco
author_facet	Pulgar B.,Dahiana Yáñez B.,Nicolás Ortega G.,Francisco
author_sort	Pulgar B.,Dahiana
title	Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional
title_short	Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional
title_full	Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional
title_fullStr	Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional
title_full_unstemmed	Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional
title_sort	mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional
publisher	Sociedad Médica de Santiago
publishDate	2019
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000700887
work_keys_str_mv	AT pulgarbdahiana mortalidada30diasposterioralaadministraciondequimioterapiasistemicaenunaunidadoncologicaregional AT yanezbnicolas mortalidada30diasposterioralaadministraciondequimioterapiasistemicaenunaunidadoncologicaregional AT ortegagfrancisco mortalidada30diasposterioralaadministraciondequimioterapiasistemicaenunaunidadoncologicaregional
_version_	1718437073240719360

Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional

Ejemplares similares